Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Front Aging Neurosci ; 16: 1381692, 2024.
Article in English | MEDLINE | ID: mdl-38524118

ABSTRACT

Background and aims: Dementia imposes a heavy burden on society and families, therefore, effective drug treatments, exploring and preventing factors associated with dementia, are paramount. To provide reference points for the best frequency of physical exercise (physical exercise), we investigated the association between frequency of PE and cognition in Chinese old adults. Methods: 16,181 Chinese participants aged 65 years or older were included in this study. Associations between PE and cognition were estimated multivariate logistic and linear regression analyses. Associations were further investigated across dementia subtypes (Alzheimer dementia, vascular dementia, and other types of dementia). Subgroup analyses were performed in different age groups, in populations with and without stroke, and those with and without hypertension. Results: PE associated with dementia after adjusting for full covariates (OR: 0.5414, 95% CI: 0.4536-0.6491, p < 0.001). Exercise performed at ≥3 times/week associated with lower risk of dementia (OR: 0.4794-0.6619, all p value <0.001). PE was associated with improved cognition (ß: 12851, p < 0.001), and any PE frequency contributed to cognitive improvement (p values for exercise performed ≥1 time/week were <0.001). Similar conclusions were identified when we repeated analyses in different dementia subtypes and age groups. Subgroup analyses suggested that the cognition of individuals without hypertension also benefitted from exercising 1-2 times/week (OR: 0.6168, 95% CI: 0.4379-0.8668, p = 0.005). Conclusion: The best exercise frequency is exercising ≥3 times/week for individuals from different dementia subtypes and age groups. While for those without hypertension, PE at 1-2 times /week is also beneficial.

2.
J Ment Health ; 30(4): 541-548, 2021 Aug.
Article in English | MEDLINE | ID: mdl-32915668

ABSTRACT

BACKGROUND: Cognitive strategies are preferred among nurses who have limited opportunities in the workplace to use behavioral strategies to cope with negative life events. AIMS: To explore whether different cognitive emotion regulation profiles could be distinguished in nurses exposed to workplace violence, and to investigate whether such profiles had differential associations with depressive symptoms. METHOD: An online survey was conducted among nurses exposed to workplace violence (N = 399). Latent profile analysis was performed to identify discrete profiles based on the use of cognitive emotion regulation strategies. The Bolck, Croon, and Hagenaars method was applied to compare the latent profiles on the depressive symptoms. RESULTS: Seven latent profiles were identified: Low Regulators, Medium Regulators, High Regulators, Intensely Adaptive Regulators, Moderately Adaptive Regulators, Intensely Maladaptive Regulators, and Moderately Maladaptive Regulators. High Regulators had the highest level of depressive symptoms. Although using less adaptive strategies, Low Regulators did not report significantly more depressive symptoms than Medium Regulators, Intensely Maladaptive and Moderately Maladaptive Regulators. CONCLUSIONS: The adaptability of cognitive emotion regulation strategies depends on the conjunction of different strategies one person has at his disposal. Cognitive emotion regulation skill training should focus on flexible implementation of strategies and decreasing use of maladaptive strategies.


Subject(s)
Emotional Regulation , Nurses , Workplace Violence , Cognition , Depression , Emotions , Humans
3.
Int J Syst Evol Microbiol ; 70(4): 2204-2210, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32038002

ABSTRACT

Two Gram-stain-positive, catalase-positive and oxidase-negative, aerobic, non-motile, cellobiose-utilizing, short-rod-shaped strains (Z28T and Z29) were isolated from faeces of Tibetan antelope (Pantholops hodgsonii) collected on the Qinghai-Tibet Plateau. Strain Z28T shared 98.1, 98.0, 97.8 and 97.4 % 16S rRNA gene similarity, 24.1, 22.8, 23.2 and 26.3 % digital DNA-DNA hybridization relatedness and 80.8, 80.0, 80.7 and 80.9 % average nucleotide identity values with Cellulomonas oligotrophica DSM 24482T, Cellulomonas flavigena DSM 20109T, Cellulomonas iranensis DSM 14785T and Cellulomonas terrae JCM 14899T, respectively. Results from further phylogenetic analyses based on the 16S rRNA gene and 148 core genes indicated that strains Z28T and Z29 were closest to C. oligotrophica DSM 24482T and C. flavigena DSM 20109T, but clearly separated from the currently recognized species of the genus Cellulomonas. The genomic DNA G+C content of strain Z28T was 75.3 mol%. The major cellular fatty acids were anteiso-C15 : 0, anteiso-C15 : 1 A, C16 : 0 and anteiso-C17 : 0. Ribose and mannose were detected as the whole-cell sugars. The major respiratory quinone was MK-9(H4) and ornithine was the diamino acid of the cell wall. The polar lipids present in strain Z28T were phosphatidylethanolamine, five phospholipids, two aminophospholipids, aminolipid and three unidentified lipids. Comparison of phenotypic and phylogenetic features between the two strains and the related organisms revealed that Z28T and Z29 represent a novel species of the genus Cellulomonas, for which the name Cellulomonas shaoxiangyii sp. nov. is proposed. The type strain is Z28T (=CGMCC 1.16477T=DSM 106200T).


Subject(s)
Antelopes/microbiology , Cellulomonas/classification , Feces/microbiology , Phylogeny , Animals , Bacterial Typing Techniques , Base Composition , Cell Wall/chemistry , Cellulomonas/isolation & purification , DNA, Bacterial/genetics , Fatty Acids/chemistry , Nucleic Acid Hybridization , Ornithine/chemistry , Phospholipids/chemistry , RNA, Ribosomal, 16S/genetics , Sequence Analysis, DNA , Tibet , Vitamin K 2/analogs & derivatives , Vitamin K 2/chemistry
4.
Mol Med Rep ; 17(2): 3336-3343, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29257284

ABSTRACT

Icariin (ICA) has been implicated in certain biological and pathological processes, including myocardial ischemia/reperfusion (I/R) injury. The aim of the present study was to investigate the role of ICA in I/R­induced cardiomyocyte injury and the potential underlying mechanism. Cell proliferation and apoptosis of H9C2 cells was determined by cell counting kit­8 and flow cytometry assays. In addition, reactive oxygen species (ROS) production in H9C2 cells was measured by flow cytometry. Reverse transcription­quantitative polymerase chain reaction and western blot assay were performed to examine the expression levels of proteins, including HSP20, B­cell lymphoma 2 (Bcl­2), cytochrome complex (Cyt­c), apoptotic protease activating factor 1 (APAF1), caspase­9 andcaspase­3, and the phosphorylation of Akt (p­Akt) in H9C2 cells. The present results demonstrated that, compared with the control group, the I/R group demonstrated significantly reduced levels of HSP20 expression and cell proliferation, and increased apoptosis and ROS production in H9C2 cells. In parallel, the expression levels of Cyt­c, APAF1, caspase­9 and caspase­3 were significantly increased in the I/R group, although Bcl­2 and p­Akt/Akt expression levels were decreased. Furthermore, compared with the I/R group, ICA treatment and/or HSP20 overexpression significantly improved cardiac function, as evidenced by promoted cell proliferation and inhibited apoptosis of H9C2 cells. The current study indicates that ICA exerts a cardioprotective effect against I/R injury, which is associated with the upregulation of HSP20.


Subject(s)
Cardiotonic Agents/pharmacology , Drugs, Chinese Herbal/pharmacology , Flavonoids/pharmacology , HSP20 Heat-Shock Proteins/genetics , Muscle Proteins/genetics , Myocardial Reperfusion Injury/drug therapy , Myocytes, Cardiac/drug effects , Up-Regulation/drug effects , Animals , Cell Line , Myocardial Reperfusion Injury/genetics , Myocardial Reperfusion Injury/pathology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Rats
5.
Immunology ; 145(2): 258-67, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25580516

ABSTRACT

Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 infection in humans can cause acute haemorrhagic colitis and severe haemolytic uraemic syndrome. The role of enterohaemolysin (Ehx) in the pathogenesis of O157:H7-mediated disease in humans remains undefined. Recent studies have revealed the importance of the inflammatory response in O157:H7 pathogenesis in humans. We previously reported that Ehx markedly induced interleukin-1ß (IL-1ß) production in human macrophages. Here, we investigated the disparity in Ehx-induced IL-1ß production between human and mouse macrophages and explored the underlying mechanism regarding the activation of NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasomes. In contrast to the effects on human differentiated THP-1 cells and peripheral blood mononuclear cells, Ehx exerted no effect on IL-1ß production in mouse macrophages and splenocytes because of a disparity in pro-IL-1ß cleavage into mature IL-1ß upon caspase-1 activation. Additionally, Ehx significantly contributed to O157:H7-induced ATP release from THP-1 cells, which was not detected in mouse macrophages. Confocal microscopy demonstrated that Ehx was a key inducer of cathepsin B release in THP-1 cells but not in mouse IC-21 cells upon O157:H7 challenge. Inhibitor experiments indicated that O157:H7-induced IL-1ß production was largely dependent upon caspase-1 activation and partially dependent upon ATP signalling and cathepsin B release, which were both involved in NLRP3 activation. Moreover, inhibition of K(+) efflux drastically diminished O157:H7-induced IL-1ß production and cytotoxicity. The findings in this study may shed light on whether and how the Ehx contributes to the development of haemolytic uraemic syndrome in human O157:H7 infection.


Subject(s)
Carrier Proteins/immunology , Escherichia coli O157 , Escherichia coli Proteins/toxicity , Hemolysin Proteins/toxicity , Hemolytic-Uremic Syndrome/immunology , Interleukin-1beta/immunology , Macrophages/immunology , Animals , Caspase 1/immunology , Cathepsin B/immunology , Cell Line, Tumor , Hemolytic-Uremic Syndrome/pathology , Humans , Inflammasomes/immunology , Macrophages/pathology , Mice , NLR Family, Pyrin Domain-Containing 3 Protein , Species Specificity
6.
Proc Natl Acad Sci U S A ; 110(9): 3495-500, 2013 Feb 26.
Article in English | MEDLINE | ID: mdl-23382200

ABSTRACT

The refractoriness of acute promyelocytic leukemia (APL) with t(11;17)(q23;q21) to all-trans retinoic acid (ATRA)-based therapy concerns clinicians and intrigues basic researchers. By using a murine leukemic model carrying both promyelocytic leukemia zinc finger/retinoic acid receptor-α (PLZF/RARα) and RARα/PLZF fusion genes, we discovered that 8-chlorophenylthio adenosine-3', 5'-cyclic monophosphate (8-CPT-cAMP) enhances cellular differentiation and improves gene trans-activation by ATRA in leukemic blasts. Mechanistically, in combination with ATRA, 8-CPT-cAMP activates PKA, causing phosphorylation of PLZF/RARα at Ser765 and resulting in increased dissociation of the silencing mediator for retinoic acid and thyroid hormone receptors/nuclear receptor corepressor from PLZF/RARα. This process results in changes of local chromatin and transcriptional reactivation of the retinoic acid pathway in leukemic cells. Meanwhile, 8-CPT-cAMP also potentiated ATRA-induced degradation of PLZF/RARα through its Ser765 phosphorylation. In vivo treatment of the t(11;17) APL mouse model demonstrated that 8-CPT-cAMP could significantly improve the therapeutic effect of ATRA by targeting a leukemia-initiating cell activity. This combined therapy, which induces enhanced differentiation and oncoprotein degradation, may benefit t(11;17) APL patients.


Subject(s)
Cell Differentiation , Cyclic AMP/analogs & derivatives , Leukemia, Promyelocytic, Acute/drug therapy , Oncogene Proteins, Fusion/metabolism , Proteolysis , Thionucleotides/therapeutic use , Translocation, Genetic , Tretinoin/therapeutic use , Animals , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Cell Differentiation/drug effects , Cell Differentiation/genetics , Chromosomes, Human, Pair 11/genetics , Chromosomes, Human, Pair 17/genetics , Cyclic AMP/pharmacology , Cyclic AMP/therapeutic use , Cyclic AMP-Dependent Protein Kinases/metabolism , Female , Humans , Leukemia, Promyelocytic, Acute/genetics , Leukemia, Promyelocytic, Acute/pathology , Mice , Mice, Inbred C57BL , Nuclear Receptor Co-Repressor 2/metabolism , Phosphorylation/drug effects , Phosphoserine/metabolism , Proteolysis/drug effects , Signal Transduction/drug effects , Survival Analysis , Thionucleotides/pharmacology , Translocation, Genetic/drug effects , Tretinoin/pharmacology
7.
Biomed Environ Sci ; 25(6): 653-62, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23228835

ABSTRACT

OBJECTIVE: To establish and compare the pulsed-field gel electrophoresis (PFGE), multiple-locus variable number tandem repeat analysis (MLVA) and automated ribotyping for subtyping of Citrobacter strains. METHODS: PFGE protocol was optimized in terms of plug preparation procedure, restriction enzymes and configuration of electrophoretic parameters. MLVA method was evaluated by finding variable number tandem repeats in two genomes of Citrobacter strains. The ribotyping was performed by using the automated RiboPrinter system. RESULTS: We optimized the plug preparation procedure, focused on the cell suspension concentration (turbidity of 2.5 to 3.5), SDS addition (no SDS needed) and lysis time (1 h), and selected the appropriate restriction enzyme (XbaI) and the electrophoretic parameters (1.0 s-20.0 s for 19 h) of PFGE. There was nearly no discriminatory power of MLVA between Citrobacter strains. For 51 Citrobacter strains, automated ribotyping gave a D-value of 0.9945, while PFGE gave a D-value of 0.9969. Both PFGE and automated ribotyping clustered strains from the same sources (with the same species from the same place at the same time identified as the same source) and divided strains from different sources (from different years, places and hosts) into different subtypes. CONCLUSION: PFGE protocol established in this paper and automated ribotyping are suitable for application in Citrobacter subtyping.


Subject(s)
Citrobacter/genetics , Electrophoresis, Gel, Pulsed-Field/methods , Minisatellite Repeats/genetics , Multilocus Sequence Typing/methods , Ribotyping/methods , Automation , Citrobacter/classification , Phylogeny
8.
Int J Cancer ; 128(1): 233-8, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-20232390

ABSTRACT

Common genetic variations in genes involved in DNA repair or response to genotoxic stress may influence both cancer susceptibility and treatment response individually or interactively. However, in acute myeloid leukemia (AML), the relevance of these genetic variations remains to be fully established. In this study, we analyzed 42 genetic variations among 15 candidate genes in 307 AML patients and 560 age-sex matched controls. Their associations with chemotherapy response were further evaluated in combination with other well-established prognostic factors. An increased risk of AML was found in individuals heterozygous for XPD 2251A>C (rs13181) with an odds ratio (OR) of 1.637 (95% confidence interval [CI]: 1.118-2.395), and the increased risk could be attributed to C allele (OR = 1.505, 95% CI: 1.061-2.134). Postchemotherapy response analysis revealed that AML patients heterozygous for ATM 4138C>T (rs3092856) or GG homozygous for TP53 215C>G (rs1042522) were independently linked to inferior treatment outcomes. These results uncover novel prognostic factors for AML patients treated with chemotherapy and may also indicate an etiological role of XPD in this disease.


Subject(s)
DNA Repair/genetics , Genetic Predisposition to Disease/genetics , Leukemia, Myeloid/genetics , Polymorphism, Single Nucleotide , Acute Disease , Adolescent , Adult , Aged , Ataxia Telangiectasia Mutated Proteins , Cell Cycle Proteins/genetics , DNA-Binding Proteins/genetics , Female , Genetic Variation , Humans , Leukemia, Myeloid/drug therapy , Leukemia, Myeloid/pathology , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prognosis , Protein Serine-Threonine Kinases/genetics , Survival Analysis , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Proteins/genetics , Xeroderma Pigmentosum Group D Protein/genetics , Young Adult
9.
Ai Zheng ; 27(11): 1150-4, 2008 Nov.
Article in Chinese | MEDLINE | ID: mdl-19000444

ABSTRACT

BACKGROUND & OBJECTIVE: Recent studies suggest strong therapeutic potentials of arsenic trioxide (As2O3) for multiple myeloma(MM), which may be due to As2O3-induced demethylation of tumor suppressor genes. This study was to explore the correlation of cell cycle alteration to SOCS-1 gene demethylation after As2O3 induction in MM cell lines in vitro. METHODS: MM cell lines U266 and RPMI8226 were used. Cell proliferation and cell cycle of MM cells after the treatment of As2O3 were assessed by MTT assay and flow cytometry, respectively. Methylation status was detected by methylation specific PCR (MSP-PCR), and gene expression of SOCS-1 was measured by real-time PCR in MM cells before and after As2O3 treatment. RESULTS: As2O3 significantly inhibited the growth of U266 and RPMI8226 cells in a dose-dependent manner. The cell cycle of U266 and RPMI8226 were arrested at G0/G1 phase. Compared with the wild type, the percentage of cells was increased at G0-G1 phase, but decreased at S phase after the treatment of As2O3 for 72 h (P < 0.05). The mRNA expression of SOCS-1 gene was significantly increased with hemi-methylation (As2O3, 0.5 micromol/L,72 h) or complete demethylation (As2O3, 1.0 micromol/L or As2O3, 2.0 micromol/L,72 h) of the SOCS-1 gene in comparison with the wide type (P<0.05). CONCLUSIONS: As2O3 could induce cell cycle alteration of MM, which might be related to demethylation and reexpression of SOCS-1 gene in MM cell lines. The study might provide a new approach to elucidate the mechanism of the antitumor effect of As2O3 in MM.


Subject(s)
Arsenicals/pharmacology , Cell Cycle/drug effects , DNA Methylation , Multiple Myeloma/pathology , Oxides/pharmacology , Suppressor of Cytokine Signaling Proteins/metabolism , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/pharmacology , Arsenic Trioxide , Arsenicals/administration & dosage , Cell Line, Tumor , Cell Proliferation , Dose-Response Relationship, Drug , Gene Expression Regulation, Neoplastic , Humans , Multiple Myeloma/metabolism , Oxides/administration & dosage , RNA, Messenger/metabolism , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins/genetics
10.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 16(5): 1064-8, 2008 Oct.
Article in Chinese | MEDLINE | ID: mdl-18928596

ABSTRACT

The aim of this study was to explore the effect of arsenic trioxide (As(2)O(3)) on the methylation status of socs-1 gene in multiple myeloma cell lines U266, RPMI8226. The cell viability was assayed by MTT method. The methylation status of socs-1 gene was detected by methylation specific PCR. The expression of socs-1 gene mRNA was determined with real-time PCR. The cell apoptosis was analyzed by flow cytometry. The results indicated that hypermethylation of CpG island of socs-1 gene was observed without expression of socs-1 in myeloma cell lines U266, RPMI8226. The expression of socs-1 gene mRNA in each myeloma cell line increased significantly after exposure to As(2)O(3) for 72 hours as compared with the cell lines of wild type (p < 0.05). And cell proliferation was significantly inhibited, both early apoptosis and later apoptosis ratios increased in dose-dependent manner. It is concluded that As(2)O(3) may induce socs-1 demethylation and up-regulate the expression of the gene. This study provides a new thought and direction for exploring possible mechanism of cell apoptosis induced by As(2)O(3) and multiple myeloma treatment by As(2)O(3).


Subject(s)
Arsenicals/pharmacology , DNA Methylation , Multiple Myeloma/genetics , Oxides/pharmacology , Suppressor of Cytokine Signaling Proteins/genetics , Apoptosis/drug effects , Arsenic Trioxide , Cell Line, Tumor , CpG Islands , Gene Expression Regulation, Neoplastic , Humans , Suppressor of Cytokine Signaling 1 Protein
11.
FEMS Microbiol Lett ; 287(1): 91-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18707625

ABSTRACT

Two C-4 methyl sterol oxidase genes (Pcerg25A and Pcerg25B) that are involved in ergosterol biosynthesis have been cloned from the penicillin-producing fungus Penicillium chrysogenum. cDNAs of both Pcerg25A and Pcerg25B have an ORF 885 bp in length, encoding a peptide of 295 residues. The deduced amino acid sequences of PcErg25A and PcErg25B show 86% identity, and have high identities to the characterized C-4 methyl sterol oxidases from Candida albicans and Saccharomyces cerevisiae. The function of Pcerg25A and Pcerg25B was identified by complementation of a yeast erg25-deficient strain. Pcerg25A is located in the DNA region containing the penicillin gene cluster, and thus its copy number is dependent on the patterns of the cluster region. Up to eight copies of Pcerg25A were found in the high-productivity strain NCPC 10086. By contrast, Pcerg25B was present in just a single copy in all tested P. chrysogenum genomes. Differences in the transcript level of either Pcerg25A or Pcerg25B were observed in different P. chrysogenum strains by real-time quantitative reverse transcriptase PCR analysis.


Subject(s)
Genes, Fungal/genetics , Mixed Function Oxygenases/genetics , Penicillins/metabolism , Penicillium chrysogenum/enzymology , Penicillium chrysogenum/genetics , Amino Acid Sequence , Cloning, Molecular , Gene Dosage , Gene Expression Regulation, Fungal , Genetic Complementation Test , Mixed Function Oxygenases/chemistry , Molecular Sequence Data , Phylogeny , Saccharomyces cerevisiae/genetics , Sequence Alignment , Sequence Homology, Nucleic Acid , Species Specificity
12.
Sheng Wu Gong Cheng Xue Bao ; 23(4): 618-22, 2007 Jul.
Article in Chinese | MEDLINE | ID: mdl-17822032

ABSTRACT

Glutathione transferases (GSTs) are a family of multifunctional proteins that mainly catalyze the conjugation of intracellular glutathione (GSH) to a wide variety of endogenous and exogenous electrophilic compounds. GSTs play important roles in stress tolerance and in the detoxification metabolism in organisms. A novel GST gene, Pc gstB, was cloned from penicillin producing fungus Penicillium chrysogenum using RT-PCR. The open reading frame (ORF) of Pc gstB was 651 bp and encoded a peptide of 216 residues. The deduced amino acids sequence had conserved GST domain and showed 65% identity to the characterized Aspergillus fumigutus gstB. The entire ORF of Pc gstB was inserted into vector pTrc99A and transformed into Escherichia coli DH5alpha. Recombinant PcGstB was overexpressed and its GST activity toward substrate 1-chloro-2,4-dinitrobenzene (CDNB) was validated.


Subject(s)
Fungal Proteins/genetics , Glutathione Transferase/genetics , Penicillium chrysogenum/enzymology , Penicillium chrysogenum/genetics , Recombinant Proteins/biosynthesis , Catalysis , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Fungal Proteins/metabolism , Genes, Bacterial/genetics , Glutathione Transferase/metabolism , Open Reading Frames , Recombinant Proteins/genetics , Sequence Analysis, Protein
13.
Biochem Biophys Res Commun ; 360(2): 453-8, 2007 Aug 24.
Article in English | MEDLINE | ID: mdl-17612506

ABSTRACT

A novel phenylacetyl-CoA ligase gene, designated phlB, was cloned and identified from the penicillin producing strain Penicillium chrysogenum based on subtractive suppression hybridization approach. The phlB gene contains a 1686-bp open-reading frame and encodes a protein of approximately 62.6 kDa. The deduced amino acid sequence shows about 35% identity to the characterized P. chrysogenum phenylacetyl-CoA ligase Phl and has a peroxisomal targeting signal on its C-terminal. Recombinant PhlB protein was overexpressed in Escherichia coli and purified by nickel affinity chromatography. Enzymatic assay confirmed that recombinant PhlB can catalyze the reaction of phenylacetic acid (PAA) with CoA to yield phenylacetyl-CoA. The expression level of phlB in the penicillin producing medium supplemented with PAA, the side chain precursor of penicillin G, was about 2.5-fold higher than that in medium without PAA. The study suggested that PhlB might participate in the activation of PAA during penicillin biosynthesis in P. chrysogenum.


Subject(s)
Coenzyme A Ligases/chemistry , Coenzyme A Ligases/metabolism , Penicillium chrysogenum/metabolism , Protein Engineering/methods , Amino Acid Sequence , Cloning, Molecular/methods , Coenzyme A Ligases/genetics , Enzyme Activation , Enzyme Stability , Molecular Sequence Data , Penicillium chrysogenum/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...